Free Trial

ACADIA Pharmaceuticals (ACAD) SEC Filings & 10K Form

$16.07
-0.15 (-0.92%)
(As of 09/6/2024 ET)

Recent ACADIA Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/20/2024
5:40 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:43 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:46 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:37 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:39 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:23 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:25 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:27 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:29 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:31 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/20/2024
3:33 PM
ACADIA Pharmaceuticals (Filer)
Form S-8 POS
08/13/2024
5:05 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:13 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Brege Laura (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
SOLAND DANIEL B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
HARRIGAN EDMUND (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Daly James M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:23 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form DEF 14A
04/15/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Thompson Elizabeth H.Z. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:58 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
7:02 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2024
6:57 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:07 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:10 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:13 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:08 AM
ACADIA Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
02/09/2024
7:35 AM
ACADIA Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
4:05 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2024
4:09 PM
ACADIA Pharmaceuticals (Issuer)
Rhodes Jennifer J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)

WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…

Click here to see a unique election-year trade
01/30/2024
8:55 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
5:00 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
6:37 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
11:46 AM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/28/2023
4:32 PM
ACADIA Pharmaceuticals (Issuer)
GAROFALO ELIZABETH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Schneyer Mark C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
5:00 PM
ACADIA Pharmaceuticals (Issuer)
Teehan Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
4:11 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:21 PM
ACADIA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
4:30 PM
ACADIA Pharmaceuticals (Issuer)
Ndu Adora (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
9:00 PM
ACADIA Pharmaceuticals (Issuer)
KIM AUSTIN D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2023
8:59 PM
ACADIA Pharmaceuticals (Issuer)
DAVIS STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
5:31 PM
ACADIA Pharmaceuticals (Issuer)
Kihara James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
12:06 PM
ACADIA Pharmaceuticals (Subject)
Kihara James (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ACAD) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners